The Genetics of Inherited Breast Cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 3, Issue 4, 1998, Pages 365-376

  Gayther, Simon A ^a   Pharoah, Paul D P ^a   Ponder, Bruce A J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

BRCA1; BRCA2; Genetics

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

BREAST TUMOR; CHROMOSOME 13; CHROMOSOME 17; CHROMOSOME MAP; FEMALE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HUMAN; OVARY TUMOR; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENES, BRCA1; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0032173682     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018779830743     Document Type: Article

References (86)

1. P. D. P. Pharoah, N. E. Day, S. Duffy, D. F. Easton, and B. A. J. Ponder (1997). Family history and the risk of breast cancer: A systematic review and meta-analysis. Int. J. Cancer 71:800-809.
2. B. Newman, M. A. Austin, and M. Lee (1988). Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high risk families. Proc. Natl. Acad. Sci. U.S.A. 85:3044-3048.
3. J. M. Hall, M. K. Lee, B. Newman, J. E. Morrow, L. A. Anderson, B. Huey, and M. King (1990). Linkage of early onset familial breast cancer to chromosome 17q21. Science 266:120-122.
4. Y. Miki, J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harsham, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, and W. Ding (1994). A strong candidate for the Hq linked breast and ovarian cancer susceptibility gene BRCAl. Science 266:66-71.
5. P. A. Futreal, Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L. M. Bennett, A. Haugen-Strano, J. Swensen, Y. Miki, et al. (1994). BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122.
6. D. F. Easton, D. T. Bishop, D. Ford, and G. P. Crockford (1993). Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 52:678-701.
7. S. A. Narod, D. Ford, P. Devilee, R. B. Barkardottir, H. T. Lynch, S. A. Smith, B. A. Ponder, B. L. Weber, J. E. Garber, J. M. Birch, et al. (1995). An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 56:254-264.
8. E. Steichen-Gersdorf, H. Gallion, D. Ford, C. Girodet, D. Easton, and R. DiCioccio (1994). Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21. Am. J. Hum. Genet. 55:870-875.
9. T. M. Smith, M. K. Lee, C. I. Szabo, N. Jerome, M. McEuen, M. Taylor, L. Hood, and M. King (1996). Complete genomic sequence and analysis of 117kb of human DNA containing the gene BRCA1. Genome Res. 6:1029-1049.
10. M. S. Chapman and I. M. Verma (1996). Transcriptional activation by BRCA1. Nature 382:678-679.
11. R. A. Jensen, M. E. Thompson, T. L. Jetton, C. I. Szabo, R. van der Meer, B. Helou, S. R. Tronick, D. L. Page, M. King, and J. T. Holt (1996). BRCA1 is excreted and exhibits properties of a granin. Nat. Genet. 12:303-308.
12. R. Scully (1997). Association of BRCA1 with RAD51 in mitotic and meiotic Cells. Cell 8:265-275.
13. S. L. Neuhausen, S. Mazoyer, L. Friedman, M. Stratton, K. Offit, A. Caligo, G. Tomlinson, L. Cannon Albright, T. Bishop, D. Kelsell, E. Solomon, B. Weber, F. Couch, J. Struewing, P. Tonin, F. Durocher, S. Narod, M. H. Skolnick, G. Lenoir, O. Serova, B. Ponder, D. Stoppa Lyonnet, D. Easton, M. C. King, and D. E. Goldgar (1996). Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: Results of an international study. Am. J. Hum. Genet. 58: 271-280.
14. J. P. Struewing, D. Abeliovich, T. Peretz, N. Avishai, M. M. Kaback, F. S. Collins, and L. C. Brody (1995). The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat. Genet. 11: 198-200.
15. M. G. Fitzgerald, D. J. MacDonald, M. Krainer, I. Hoover, N. E. O, H. Unsal, A. S. Silva, D. M. Finkelstein, R. P. Beer, C. Englert, D. C. Sgroi, B. L. Smith, J. W. Younger, J. E. Garber, R. B. Duda, K. A. Mayzel, K. J. Isselbacher, S. H. Friend, and D. A. Haber (1996). Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N. Engl. J. Med. 334:143-149.
16. K. Offit, T. Gilewski, P. McGuire, A. Schluger, H. Hampel, K. Brown, J. Swensen, S. Neuhausen, M. Skolnick, L. Norton, and D. Goldgar (1996). Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347:1643-1645.
17. J. S. Humphrey, A. Salim, M. R. Erdos, F. S. Collins, L. C. Brody, and R. D. Klausner (1997). Human BRCA1 inhibits growth in yeast: Potential use in diagnostic testing. Proc. Natl. Acad. Sci. U.S.A. 94:5820-5825.
18. R. Wooster, S. L. Neuhausen, J. Mangion, Y. Quirk, D. Ford, N. Collins, K. Nguyen, S. Seal, T. Tran D. Averill, et al. (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090.
19. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, G. Micklem, R. Barfoot, R. Hamoudi, S. Patel, C. Rice, P. Biggs, Y. Hashim, A. Smith, F. Connor, A. Arason, J. Gudmundsson, D. Ficenec, D. Kelsell, D. Ford, P. Tonin, D. T. Bishop, N. K. Spurr, B. A. J. Ponder, R. Eeles, J. Peto, P. Devilee, C. Cornelisse, H. Lynch, S. Narod, G. Lenoir, V. Egilsson, R. B. Barkadottir, D. F. Easton, D. R. Bentley, P. A. Futreal, A. Ashworth, and M. R. Stratton (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.
20. A. K. C. Wong, R. Pero, P. A. Ormonde, S. V. Tavtigian, and P. L. Bartel (1997). RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene BRCA2. J. Biol. Chem. 272:31941-31944.
21. S. K. Sharan, M. Morimatsu, U. Albrecht, D. Lim, E. Regel, C. Dinh, A. Sands, G. Eichele, P. Hasty, and A. Bradley (1997). Embryonic lethality and radiation hyper sensitivity mediated by Rad51 in mice lacking BRCA2. Nature 386:804-810.
22. S. Neuhausen, T. Gilewski, L. Norton, T. Tran, P. McGuire, J. Swensen, H. Hampel, P. Borgen, K. Brown, M. Skolnick, D. Shattuck Eidens, S. Jhanwar, D. Goldgar, and K. Offit (1996). Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat. Genet. 13: 126-128.
23. S. Thorlacius, G. Olafsdottir, L. Tryggvadottir, S. Neuhausen, J. G. Jonasson, S. V. Tavtigian, H. Tulinius, H. M. Ogmundsdottir, and J. Eyfjord (1996). A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet. 13:117-119.
24. D. Malkin, F. Li, F. F. Strong, J., C. Nelson, D. Kim, J. Kassel, M. Gryka, F. Bischoff, M. Tainsky, and S. Friend (1990). Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250:1233-1238.
25. A. L. Borresen, T. I. Andersen, J. Garber, N. Barbier-Piraux, S. Thorlacius, J. Eyfjord, L. Ottestad, B. Smith-Sorensen, E. Hovig, D. Malkin, et al. (1992). Screening for germ line TP53 mutations in breast cancer patients. Cancer Res. 52: 3234-3236.
26. E. Rhei, L. Kang, F. Bogomolniy, M. G. Federici, P. I. Borgen, and J. Boyd (1997). Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 57:3657-3659.
27. D. Ford, D. F. Easton, M. Stratton, S. Narod, D. Goldgar, P. Devilee, D. T. Bishop, B. Weber, G. Lenoir, J. Chang-Claude, H. Sobol, M. D. Teare, J. Struewing, A. Arason, S. Scherneck, J. Peto, T. R. Rebbeck, P. Tonin, S. Neuhausen, R. Barkadottir, J. Eyfjord, H. Lynch, B. A. J. Ponder, S. A. Gayther, J. M. Birch, A. Lindblom, D. Stoppa-Lyonnet, Y. Bignon, A. Borg, U. Hamann, N. Haites, R. J. Scott, C. M. Maugard, H. Vasen, S. Seitz, L. A. Cannon-Albright, A. Schofield, M. Z. Hedman, and Breast Cancer Linkage Consortium (1998). Genetic hetero-geneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet, (in press).
28. J. P. Streuwing, P. Hartge, S. Wacholder, S. M. Baker, M. Berlin, M. McAdams, M. M. Timmerman, L. C. Brody, and M. A. Tucker (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med. 336:1401-1408.
29. S. A. Gayther, W. Warren, S. Mazoyer, P. A. Russell, P. A. Harrington, M. Chiano, S. Seal, R. Hamoudi, R. E. J. van, A. M. Dunning, et al. (1995). Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotyp e correlation. Nat. Genet. 11:428-433.
30. S. A. Gayther, J. Mangion, P. Russell, S. Seal, R. Barfoot, B. A. Ponder, M. R. Stratton, and D. Easton (1997). Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat. Genet. 15: 103-105.
31. T. G. Krontiris, B. Devlin, D. D. Karp, N. J. Robert, and N. Risch (1993). An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N. Engl J. Med. 329:517-523.
32. C. M. Phelan, T. R. Rebbeck, B. L. Weber, P. Devilee, M. H. Ruttledge, H. T. Lynch, G. M. Lenoir, M. R. Stratton, D. F. Easton, B. A. Ponder, L. Cannon Albright, C. Larsson, D. E. Goldgar, and S. A. Narod (1996). Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat. Genet. 12:309-311.
33. P. Athma, R. Rappaport, and M. Swift (1996). Molecular genotyping shows that ataxia-telangie ctasia heterozygotes are predisposed to breast cancer. Cancer Genet. Cytogenet. 92: 130-134.
34. M. G. Fitzgerald, J. M. Bean, S. R. Hegde, H. Unsal, D. J. MacDonald, D. P. Harkin, D. M. Finkelstein, K. J. Isselbacher, and D. A. Haber (1997). Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat. Genet. 15: 307-310.
35. E. B. Claus, N. Risch, and W. D. Thompson (1991). Genetic analysis of breast cancer in the Cancer and Steroid Hormone study. Am. J. Hum. Genet. 48:232-242.
36. L. Iselius, J. Slack, and M. Littler (1991). Genetic epidemiology of breast cancer in Britain. Ann. Hum. Genet. 55:151-159.
37. S. D. Merajver, T. M. Pham, R. F. Caduff, M. Chen, E. L. Poy, K. A. Cooney, B. L. Weber, F. S. Collins, C. Johnston, and T. S. Frank (1995). Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat. Genet. 9:439-443.
38. Y. Miki, T. Katagiri, F. Kasumi, T. Yoshimoto, and Y. Nakamura (1996). Mutation analysis in the BRCA2 gene in primary breast cancers. Nat. Genet. 13:245-247.
39. K. A. Foster, P. Harrington, J. Kerr, P. Russell, R. A. DiCioccio, I. V. Scott, I. Jacobs, G. Chenevix-Trench, B. A. Ponder, and S. A. Gayther (1996). Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res 56: 3622-3625.
40. P. Zuppan, J. M. Hall, M. K. Lee, M. Ponglikitmongkol, and M. C. King (1991). Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am. J. Hum. Genet. 48:1065-1068.
41. F. Kerangueven, L. Essioux, A. Dib, T. Noguchi, F. Allione, J. Geneix, M. Longy, R. Lidereau, F. Eisinger, M. J. Pebusque, et al. (1995). Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene 10: 1023-1026.
42. E. B. Claus, J. M. Schildkraut, W. D. Thompson, and N. J. Risch (1996). The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324.
43. M. Swift, D. Morrell, R. B. Massey, and C. L. Chase (1991). Incidence of cancer in 161 families affected by ataxia- telangiectasia. N. Engl. J. Med. 325:1831-1836.
44. J. Simard, P. Tonin, F. Durocher, K. Morgan, J. Rommens, S. Gingras, C. Samson, J. F. Leblanc, C. Belanger, F. Dion, et al. (1994). Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat. Genet. 8:392-398.
45. D. Stoppa Lyonnet, P. Laurent Puig, L. Essioux, S. Pages, G. Ithier, L. Ligot, A. Fourquet, R. J. Salmon, K. B. Clough, P. Pouillart, C. Bonaiti Pellie, and G. Thomas (1997). BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am. J. Hum. Genet. 60:1021-1030.
46. J. P. Peyrat, P. Vennin, L. Hornez, and J. Bonneterre (1997). [Germ-line mutation of BRCA1 in patients with breast and/or ovarian cancer in high risk families in Northern France]. Bull. Cancer 84:41-46.
47. U. Hamann, H. Brauch, A. M. Garvin, G. Bastert, and R. J. Scott (1997). German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene. Genes Chromosomes Cancer 18:126-132.
48. B. Jandrig, K. Grade, S. Seitz, B. Waindzoch, M. Muller, E. Bender, A. Nothnagel, K. Rohde, P. M. Schlag, R. Kath, K. Hoffken, and S. Scherneck (1996). BRCA1 mutations in German breast-cancer families. Int. J. Cancer 68:188-192.
49. T. Peelen, M. van Vliet, A. Petrij Bosch, R. Mieremet, C. Szabo, A. M. van den Ouweland, F. Hogervorst, R. Brohet, M. J. Ligtenberg, E. Teugels, R. van der Luijt, A. H. van der Hout, J. J. Gille, G. Pals, I. Jedema, R. Olmer, I. van Leeuwen, B. Newman, M. Plandsoen, M. van der Est, G. Brink, S. Hageman, P. J. Arts, M. M. Bakker, P. Devilee, et al. (1997). A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am. J. Hum. Genet. 60:1041-1049.
50. M. Takano, H. Aida, I. Tsuneki, K. Takakuwa, I. Hasegawa, H. Tanaka, M. Saito, S. Tsuji, T. Sonoda, M. Hatae, J. T. Chen, K. Takahashi, K. Hasegawa, N. Toyoda, N. Saito, M. Yakushiji, T. Araki, and K. Tanaka (1997). Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in Japan. Jpn. J. Cancer Res. 88:407-413.
51. M. Montagna, M. Santacatterina, B. Corneo, C. Menin, O. Serova, G. M. Lenoir, L. Chieco Bianchi, and E. D'Andrea (1996). Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families. Cancer Res. 56:5466-5469.
52. M. A. Caligo, C. Ghimenti, G. Cipollini, S. Ricci, I. Brunetti, V. Marchetti, R. Olsen, S. Neuhausen, D. Shattuck Eidens, P. F. Conte, M. H. Skolnick, and G. Bevilacqua (1996). BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations. Oncogene 13:1483-1488.
53. V. M. De Benedetti, P. Radice, P. Mondini, G. Spatti, A. Conti, M. T. Illeni, M. A. Caligo, G. Cipollini, G. Bevilaqua, S. Pilotti, and M. A. Pierotti (1996). Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test. Oncogene 13:1353-1357.
54. T. I. Andersen, A. L. Borresen, and P. Moller (1996). A common BRCA1 mutation in Norwegian breast and ovarian cancer families? Am. J. Hum. Genet. 59:486-487.
55. S. A. Gayther, P. Harrington, P. Russell, G. Kharkevich, R. F. Garkavtseva, and B. A. Ponder (1997). Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am. J. Hum. Genet. 60:1239-1242.
56. M. Zelada Hedman, B. Wasteson Arver, A. Claro, J. Chen, B. Werelius, H. Kok, K. Sandelin, S. Hakansson, T. I. Andersen, A. Borg, A. L. Borresen Dale, and A. Lindblom (1997). A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res. 57:2474-2474.
57. C. F. Xu, J. A. Chambers, H. Nicolai, M. A. Brown, Y. Hujeirat, S. Mohammed, S. Hodgson, D. P. Kelsell, N. K. Spurr, D. T. Bishop, and E. Solomon (1997). Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer 18:102-210.
58. L. H. Castilla, F. J. Couch, M. R. Erdos, K. F. Hoskins, K. Calzone, J. E. Garber, J. Boyd, M. B. Lubin, M. L. Deshano, L. C. Brody, et al. (1994). Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat. Genet. 8:387-391.
59. J. P. Struewing, L. C. Brody, M. R. Erdos, R. G. Kase, T. R. Giambarresi, S. A. Smith, F. S. Collins, and M. A. Tucker (1995). Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am. J. Hum. Genet. 57:1-7.
60. J. F. Arena, S. Smith, M. Plewinska, L. Gayol, E. Perera, P. Murphy, and H. Lubs (1996). BRCA1 mutations in African-American women. Am. J. Hum. Genet. 59:A34
61. Q. Gao, S. Neuhausen, S. Cummings, M. Luce, and O. I. Olopade (1997). Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am. J. Hum. Genet. 60:1233-1236.
62. S. J. Ramus, Z. Kote Jarai, L. S. Friedman, M. van der Looij, S. A. Gayther, B. Csokay, B. A. Ponder, and E. Olah (1997). Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Am. J. Hum. Genet. 60:1242-1246.
63. R. Inoue, T. Fukutomi, T. Ushijima, Y. Matsumoto, T. Sugimura, and M. Nagao (1995). Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res. 55:3521-3524.
64. R. Inoue, T. Ushijima, T. Fukutomi, A. Fukami, H. Sugimura, S. Inoue, H. Okonogi, T. Sugimura, Y. Matsumoto, and M. Nagao (1997). BRCA2 germline mutations in Japanese breast cancer families. Int. J. Cancer 74:199-204.
65. E. Levy Lahad, R. Catane, S. Eisenberg, B. Kaufman, G. Hornreich, E. Lishinsky, M. Shohat, B. L. Weber, U. Beller, A. Lahad, and D. Halle (1997). Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am. J. Hum. Genet. 60:1059-1067.
66. O. M. Serova, S. Mazoyer, N. Puget, V. Dubois, P. Tonin, Y. Y. Shugart, D. Goldgar, S. A. Narod, H. T. Lynch, and G. M. Lenoir (1997). Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am. J. Hum. Genet. 60:486-495.
67. E. L. Schubert, M. K. Lee, H. C. Mefford, R. H. Argonza, J. E. Morrow, J. Hull, J. L. Dann, and M. C. King (1997). BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am. J. Hum. Genet. 60:1031-1040.
68. S. Hakansson, O. Johannsson, U. Johansson, G. Sellberg, N. Loman, A. M. Gerdes, E. Holmberg, N. Dahl, N. Pandis, U. Kristoffersson, H. Olsson, and A. Borg (1997). Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am. J. Hum. Genet. 60:1068-1078.
69. C. M. Phelan, J. M. Lancaster, P. Tonin, C. Gumbs, C. Cochran, R. Carter, P. Ghadirian, C. Perret, R. Moslehi, F. Dion, M. C. Faucher, K. Dole, S. Karimi, W. Foulkes, H. Lounis, E. Warner, P. Goss, D. Anderson, C. Larsson, S. A. Narod, and P. A. Futreal (1996). Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat. Genet. 13:120-122.
70. P. Vehmanen, L. S. Friedman, H. Eerola, L. Sarantaus, S. Pyrhonen, B. A. Ponder, T. Muhonen, and H. Nevanlinna (1997). A low proportion of BRCA2 mutations in Finnish breast cancer families. Am. J. Hum. Genet. 60:1050-1058.
71. O. M. Serova Sinilnikova, L. Boutrand, D. Stoppa Lyonnet, B. Bressac de Paillerets, V. Dubois, C. Lasset, N. Janin, Y. J. Bignon, M. Longy, C. Maugard, R. Lidereau, D. Leroux, T. Frebourg, S. Mazoyer, and G. M. Lenoir (1997). BRCA2 mutations in hereditary breast and ovarian cancer in France [letter]. Am. J. Hum. Genet. 60:1236-1239.
72. S. A. Gayther, P. Harrington, P. Russell, G. Kharkevich, R. F. Garkavtseva, B. A. J. Ponder, and UKCCCR Familial Ovarian Cancer Study Group (1996). Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. Am. J. Hum. Genet. 58:451-456.
73. S. V. Tavtigian, J. Simard, J. Rommens, F. Couch, D. Shattuck Eidens, S. Neuhausen, S. Merajver, S. Thorlacius, K. Offit, D. Stoppa Lyonnet, C. Belanger, R. Bell, S. Berry, R. Bogden, Q. Chen, T. Davis, M. Dumont, C. Frye, T. Hattier, S. Jammulapati, T. Janecki, P. Jiang, R. Kehrer, J. F. Leblanc, D. E. Goldgar, et al. (1996). The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet. 12:333-337.
74. F. J. Couch, L. M. Farid, M. L. Deshano, S. V. Tavtigian, K. Calzone, L. Campeau, Y. Peng, B. Bogden, Q. Chen, S. Neuhausen, D. Shattuck Eidens, A. Godwin, M. Daly, D. M. Radford, S. Sedlacek, J. Rommens, J. Simard, J. Garber, S. Merajver, and B. L. Weber (1996). BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat. Genet. 13:123-125.
75. F. J. Couch, M. L. Deshano, M. A. Blackwood, K. Calzone, J. Stopfer, L. Campeau, A. Ganguly, T. Rebbeck, and B. L. Weber (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 336:1409-1415.
76. G. Ithier, M. Girard, and D. Stoppa Lyonnet (1996). Breast cancer and BRCA1 mutations [letter]. N. Engl. J. Med. 334: 1198-1199.
77. M. Krainer, S. Silva Arrieta, M. G. Fitzgerald, A. Shimada, C. Ishioka, R. Kanamaru, D. J. MacDonald, H. Unsal, D. M. Finkelstein, A. Bowcock, K. J. Isselbacher, and D. A. Haber (1997). Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N. Engl. J. Med 336:1416-1421.
78. T. Katagiri, M. Emi, I. Ito, K. Kobayashi, M. Yoshimoto, T. Iwase, F. Kasumi, Y. Miki, M. H. Skolnick, and Y. Nakamura (1996). Mutations in the BRCA1 gene in Japanese breast cancer patients. Hum. Mutat. 7:334-339.
79. E. Garcia Patino, B. Gomendio, M. Provencio, J. M. Silva, J. M. Garcia, P. Espana, and F. Bonilla (1998). Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations. J. Clin. Oncol. 16:115-120.
80. D. Abeliovich, L. Kaduri, I. Lerer, N. Weinberg, G. Amir, M. Sagi, J. Zlotogora, N. Heching, and T. Peretz (1997). The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am. J. Hum. Genet. 60:505-514.
81. L. S. Friedman, S. A. Gayther, T. Kurosaki, D. Gordon, B. Noble, G. Casey, B. A. Ponder, and H. Anton Culver (1997). Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am. J. Hum. Genet. 60:313-319.
82. A. Langston, K. E. Malone, J. D. Thompson, J. R. Daling, and E. A. Ostrander (1996). BRCA1 mutations in a population-based sample of young women with breast cancer. N. Engl. J. Med. 334:137-142.
83. B. Newman, H. Mu, L. M. Butler, R. C. Millikan, P. G. Moorman, and M. King (1998). Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. J.A.M.A. 279:915-921.
84. K. E. Malone, J. R. Daling, J. D. Thompson, C. A. O'Brien, L. V. Francisco, and E. A. Ostrander (1998). BRCA1 mutations and breast cancer in the general population. J.AM.A 279: 922-929.
85. S. Thorlacius, S. Sigurdsson, H. Bjarnadottir, G. Olafsdottir, J. G. Jonasson, L. Tryggvadottir, H. Tulinius, and J. E. Eyfjord (1997). Study of a single BRCA2 mutation with high carrier frequency in a small population. Am. J. Hum. Genet. 60:1079-1084.
86. G. Johannesdottir, J. Gudmundsson, J. T. Bergthorsson, A. Arason, B. A. Agnarsson, G. Eiriksdottir, O. T. Johannsson, A. Borg, S. Ingvarsson, D. F. Easton, V. Egilsson, and R. B. Barkardottir (1996). High prevalence of the 999de15 mutation in Icelandic breast and ovarian cancer patients. Cancer Res. 56:3663-3665.